Valuation Pressure BioSciences, Inc.
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
|
Market Closed -
OTC Markets
21:43:58 23/03/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000500 USD | -.--% |
|
-.--% | - |
Company Valuation: Pressure BioSciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3.942 | 3 | 8.309 | 18.35 | 15.89 | 7.769 |
| Change | - | -23.9% | 177.01% | 120.88% | -13.44% | -51.1% |
| Enterprise Value (EV) 1 | 8.843 | 10.93 | 17.89 | 32.86 | 36.41 | 30.57 |
| Change | - | 23.54% | 63.72% | 83.73% | 10.8% | -16.03% |
| P/E | -0.15x | -0.16x | -0.4x | -0.68x | -0.81x | -0.22x |
| PBR | -0.62x | -0.26x | -0.52x | -0.95x | -0.54x | -0.36x |
| PEG | - | 0x | 0x | 0x | 0x | 0.03x |
| Capitalization / Revenue | 1.6x | 1.66x | 6.81x | 9.17x | 9.19x | 3.93x |
| EV / Revenue | 3.6x | 6.04x | 14.7x | 16.4x | 21.1x | 15.5x |
| EV / EBITDA | -2.02x | -1.92x | -4.01x | -8.06x | -7.62x | -3.26x |
| EV / EBIT | -1.98x | -1.88x | -3.9x | -7.85x | -7.43x | -3.22x |
| EV / FCF | -1.8x | -4.29x | -5.03x | -3.13x | -7.97x | -2.64x |
| FCF Yield | -55.6% | -23.3% | -19.9% | -32% | -12.6% | -37.9% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -15.33 | -7.984 | -5.322 | -3.418 | -1.61 | -1.508 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 2.458 | 1.81 | 1.221 | 2.002 | 1.729 | 1.978 |
| EBITDA 1 | -4.383 | -5.682 | -4.458 | -4.075 | -4.779 | -9.391 |
| EBIT 1 | -4.477 | -5.806 | -4.586 | -4.185 | -4.898 | -9.503 |
| Net income 1 | -9.699 | -11.66 | -16.01 | -20.15 | -16.08 | -29.31 |
| Net Debt 1 | 4.901 | 7.925 | 9.577 | 14.51 | 20.53 | 22.8 |
| Reference price 2 | 2.250000 | 1.250000 | 2.120000 | 2.310000 | 1.300000 | 0.330000 |
| Nbr of stocks (in thousands) | 1,752 | 2,400 | 3,919 | 7,945 | 12,221 | 23,543 |
| Announcement Date | 16/04/19 | 14/04/20 | 15/04/21 | 05/04/22 | 12/04/23 | 07/06/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 21.48K | |
| 34.53x | 5.85x | 22.47x | 0.28% | 249B | |
| 36.99x | 6.96x | 21.81x | 0.63% | 162B | |
| 51.68x | 12.65x | 27.12x | -.--% | 157B | |
| 17.34x | 3.44x | 11.18x | -.--% | 66.22B | |
| 49.46x | 12.26x | 27.02x | -.--% | 52.3B | |
| 20.5x | 2.46x | 12.41x | 2.46% | 52.18B | |
| 35.31x | 7.06x | 22.39x | -.--% | 51.34B | |
| 33.72x | 6.68x | 22.73x | 0.59% | 48.79B | |
| 79.42x | 7.56x | 22.95x | -.--% | 44.57B | |
| Average | 39.88x | 7.21x | 21.12x | 0.44% | 88.35B | |
| Weighted average by Cap. | 39.06x | 7.46x | 22.04x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PBIO Stock
- Valuation Pressure BioSciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
